.jpg)
CHRONIC FATIGUE, FIBROMYALGIA:
CHRONIC FATIGUE SYNDROME
Different names for ONE problem?
Myalgic Encephalomyelitis
Myalgic Encephalopathy
Post Viral Fatigue
Low Natural Killer Cell Disease
Chronic Epstein-Barr Disease
Chronic Fatigue and Immune Dysfunction Syndrome (CFIDS)
Burn-Out Syndrome
Neuro-endocrine-immune Dysfunction Syndrome
Chronic Mononucleosis Syndrome
Myalgic Encephalomyelitis
Atypical Poliomyelitis
Epidemic Vasculitis
Epidemic Neuromyasthenia
CFS
Fibromyalgia
Post-infectious-fatigue-syndrome
Yuppie flu
Medical Aspects of Chronic Fatigue Syndrome
- Biochemistry disturbance
- Immune System disturbance incl. microbial diseases
(Viruses like CMV, HHV-6 and EBV and bacteria infection)
Disturbance of HPA-Axis
Psychological problems
Hormonal Imbalance
Neurally Mediated Hypotension
Cardiomyopathy and mitochondria activity
Allergies
We use both: systemic and non-systemic Laser Therapy (Photobiomodulation) to support the treatment ofv Chronic Fatigue Symptoms and Fibromyalgia/muscle fatigue.
A 2006 study shows the effectiveness of LLLT in fibromyalgia/Fatigue:
Journal of Back and Musculoskeletal Rehabilitation 19 (2006) 135–140 135 IOS Press
Long-term efficacy of low level laser therapy in women with fibromyalgia: A
placebo-controlled study
Onur Armagan, Funda Tascioglu, Ayse Ekim and Cengiz Oner
Osmangazi University, Faculty of Medicine, Departments of Physical Therapy and Rehabilitation, Eskisehir, Turkey
Abstract. Aim: To investigate the efficacy of low level laser therapy (LLLT) in fibromyalgia patients.
Materials and Methods: Thirty-four fibromyalgia patients were randomly assigned to LLLT (n = 16) and placebo laser groups (n = 16). Outcome measures included number of tender points (NTP), Fibromyalgia Impact Questionnaire (FIQ), morning stiffness, global improvement as reported on a verbal scale (VSGI), and total myalgia score. Clinical evaluations were performed before, immediately after, and six months after the treatment.
Results: In the LLLT group, significant improvement was observed in clinical parameters at the end of the treatment (p < 0.01). On the other hand, significant improvements were observed only in the number of tender points and morning stiffness in the placebo group (p < 0.05). In comparing the groups, significant improvements were detected in scores of FIQ, VSGI, and total myalgia in the active laser group (p < 0.05). The clinical evaluations performed after six months demonstrated improvements in the clinical parameters only in the LLLT group (p < 0.05). When the groups were compared with each other, significant improvements were found in the LLLT group (p < 0.05).
Conclusion: Our results suggest that LLLT has both short- and long-term effectiveness in the treatment of fibromyalgia.
You can download the study here